MENU
+Compare
SRDX
Stock ticker: NASDAQ
AS OF
Jul 25, 04:59 PM (EDT)
Price
$36.01
Change
+$3.96 (+12.36%)
Capitalization
397.04M

SRDX Surmodics Forecast, Technical & Fundamental Analysis

Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays... Show more

SRDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for SRDX with price predictions
Jul 24, 2025

SRDX's RSI Oscillator peaks and leaves overbought zone

The 10-day RSI Indicator for SRDX moved out of overbought territory on July 24, 2025. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 25 instances where the indicator moved out of the overbought zone. In of the 25 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SRDX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

SRDX broke above its upper Bollinger Band on July 23, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 03, 2025. You may want to consider a long position or call options on SRDX as a result. In of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for SRDX just turned positive on July 03, 2025. Looking at past instances where SRDX's MACD turned positive, the stock continued to rise in of 51 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SRDX advanced for three days, in of 293 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SRDX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.250) is normal, around the industry mean (24.694). P/E Ratio (71.513) is within average values for comparable stocks, (77.706). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (2.838) is also within normal values, averaging (43.573).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SRDX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
SRDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

SRDX is expected to report earnings to rise 42.31% to -18 cents per share on July 30

Surmodics SRDX Stock Earnings Reports
Q2'25
Est.
$-0.19
Q1'25
Missed
by $0.04
Q4'24
Beat
by $0.08
Q3'24
Beat
by $0.07
Q2'24
Beat
by $0.07
The last earnings report on April 30 showed earnings per share of -12 cents, missing the estimate of -9 cents. With 230.61K shares outstanding, the current market capitalization sits at 397.04M.
A.I. Advisor
published General Information

General Information

a provider of surface modification and in vitro diagnostic technologies to the healthcare industry

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
9924 West 74th Street
Phone
+1 952 500-7000
Employees
376
Web
https://www.surmodics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VLDX0.480.01
+1.26%
Velo3D, Inc.
AGESF65.01N/A
N/A
ageas SA/NV
PGENY2.85N/A
N/A
Pigeon Corp.
RTPPF61.66N/A
N/A
Rio Tinto plc
XXMMF0.08N/A
N/A
XIMEN MINING CORP

SRDX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SRDX has been loosely correlated with PXMBF. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if SRDX jumps, then PXMBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRDX
1D Price
Change %
SRDX100%
-1.20%
PXMBF - SRDX
41%
Loosely correlated
N/A
BLCO - SRDX
30%
Poorly correlated
-1.90%
BDX - SRDX
30%
Poorly correlated
+0.58%
TFX - SRDX
29%
Poorly correlated
-0.89%
ATRC - SRDX
28%
Poorly correlated
-2.11%
More